57 FeiY.TsoiM
GP prescribing guide for Otago and Southland Wegovy (semaglutide) is now available in Dunedin as part of a structured, evidence-based obesity treatment programme through Southern Weight Loss
As seen in (Fig
In addition to main manifestations of HDP, such as maternal hypertension, proteinuria, and fetal growth restriction (232234), fetal brains also exhibited changes in response to HDP exposure, but their direct relevance to ASD remains unclear
However, when semaglutide is combined with insulin therapy or insulin-stimulating diabetes medications like sulfonylureas, the additive effect can push blood glucose too low, creating hypoglycemic episodes
Acknowledgments The authors are grateful to Claire Vandervenet and Franoise Darthuy for helpful technical assistance, and to Jean-Pierre Bronowicki and the other investigators of the clinical trial from which the samples have been obtained